IBDEI0T8 ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,14145,1,3,0)
 ;;=3^728.71
 ;;^UTILITY(U,$J,358.3,14145,1,5,0)
 ;;=5^Plantar Fibromatosis/Fasciitis
 ;;^UTILITY(U,$J,358.3,14145,2)
 ;;=^272598
 ;;^UTILITY(U,$J,358.3,14146,0)
 ;;=757.39^^74^863^13
 ;;^UTILITY(U,$J,358.3,14146,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14146,1,3,0)
 ;;=3^757.39
 ;;^UTILITY(U,$J,358.3,14146,1,5,0)
 ;;=5^Porokeratosis
 ;;^UTILITY(U,$J,358.3,14146,2)
 ;;=^87938
 ;;^UTILITY(U,$J,358.3,14147,0)
 ;;=696.1^^74^863^14
 ;;^UTILITY(U,$J,358.3,14147,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14147,1,3,0)
 ;;=3^696.1
 ;;^UTILITY(U,$J,358.3,14147,1,5,0)
 ;;=5^Psoriaisis
 ;;^UTILITY(U,$J,358.3,14147,2)
 ;;=^87816
 ;;^UTILITY(U,$J,358.3,14148,0)
 ;;=443.9^^74^863^1
 ;;^UTILITY(U,$J,358.3,14148,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14148,1,3,0)
 ;;=3^443.9
 ;;^UTILITY(U,$J,358.3,14148,1,5,0)
 ;;=5^PVD
 ;;^UTILITY(U,$J,358.3,14148,2)
 ;;=^184182
 ;;^UTILITY(U,$J,358.3,14149,0)
 ;;=686.1^^74^863^15
 ;;^UTILITY(U,$J,358.3,14149,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14149,1,3,0)
 ;;=3^686.1
 ;;^UTILITY(U,$J,358.3,14149,1,5,0)
 ;;=5^Pyogenic Granuloma
 ;;^UTILITY(U,$J,358.3,14149,2)
 ;;=^101548
 ;;^UTILITY(U,$J,358.3,14150,0)
 ;;=337.1^^74^863^5
 ;;^UTILITY(U,$J,358.3,14150,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14150,1,3,0)
 ;;=3^337.1
 ;;^UTILITY(U,$J,358.3,14150,1,5,0)
 ;;=5^Periph Auto Neuro
 ;;^UTILITY(U,$J,358.3,14150,2)
 ;;=^268435
 ;;^UTILITY(U,$J,358.3,14151,0)
 ;;=357.2^^74^863^12
 ;;^UTILITY(U,$J,358.3,14151,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14151,1,3,0)
 ;;=3^357.2
 ;;^UTILITY(U,$J,358.3,14151,1,5,0)
 ;;=5^Polyneuropathy
 ;;^UTILITY(U,$J,358.3,14151,2)
 ;;=^96321
 ;;^UTILITY(U,$J,358.3,14152,0)
 ;;=443.81^^74^863^4
 ;;^UTILITY(U,$J,358.3,14152,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14152,1,3,0)
 ;;=3^443.81
 ;;^UTILITY(U,$J,358.3,14152,1,5,0)
 ;;=5^Periph Angiopathy
 ;;^UTILITY(U,$J,358.3,14152,2)
 ;;=^92164
 ;;^UTILITY(U,$J,358.3,14153,0)
 ;;=337.22^^74^864^1
 ;;^UTILITY(U,$J,358.3,14153,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14153,1,3,0)
 ;;=3^337.22
 ;;^UTILITY(U,$J,358.3,14153,1,5,0)
 ;;=5^Reflex Sympathetic Dystrophy LE
 ;;^UTILITY(U,$J,358.3,14153,2)
 ;;=^295725
 ;;^UTILITY(U,$J,358.3,14154,0)
 ;;=845.09^^74^864^3
 ;;^UTILITY(U,$J,358.3,14154,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14154,1,3,0)
 ;;=3^845.09
 ;;^UTILITY(U,$J,358.3,14154,1,5,0)
 ;;=5^Rupture of Achilles Tendon
 ;;^UTILITY(U,$J,358.3,14154,2)
 ;;=Rupture of Achilles Tendon^274511
 ;;^UTILITY(U,$J,358.3,14155,0)
 ;;=845.00^^74^864^4
 ;;^UTILITY(U,$J,358.3,14155,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14155,1,3,0)
 ;;=3^845.00
 ;;^UTILITY(U,$J,358.3,14155,1,5,0)
 ;;=5^Rupture of Ankle Tendon
 ;;^UTILITY(U,$J,358.3,14155,2)
 ;;=Rupture of Ankle Tendon^274507
 ;;^UTILITY(U,$J,358.3,14156,0)
 ;;=V54.01^^74^864^2
 ;;^UTILITY(U,$J,358.3,14156,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14156,1,3,0)
 ;;=3^V54.01
 ;;^UTILITY(U,$J,358.3,14156,1,5,0)
 ;;=5^Removal Int Fixation Dev
 ;;^UTILITY(U,$J,358.3,14156,2)
 ;;=^329975
 ;;^UTILITY(U,$J,358.3,14157,0)
 ;;=.5^1^74^865^.5^Traumatic- See Sprains^^1
 ;;^UTILITY(U,$J,358.3,14157,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14157,1,3,0)
 ;;=3
 ;;^UTILITY(U,$J,358.3,14157,1,5,0)
 ;;=5
 ;;^UTILITY(U,$J,358.3,14158,0)
 ;;=709.2^^74^865^2
 ;;^UTILITY(U,$J,358.3,14158,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14158,1,3,0)
 ;;=3^709.2
 ;;^UTILITY(U,$J,358.3,14158,1,5,0)
 ;;=5^Scarring
 ;;^UTILITY(U,$J,358.3,14158,2)
 ;;=^108131
 ;;^UTILITY(U,$J,358.3,14159,0)
 ;;=733.99^^74^865^3
 ;;^UTILITY(U,$J,358.3,14159,1,0)
 ;;=^358.31IA^5^2
